Related Experiment Video
Updated: Jan 12, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
Published on: March 28, 2018
Dietary and Lifestyle Risk Factors in Primary Sclerosing Cholangitis: In Search of Mechanistic Explanations and
Ruslan A Mammadov1, Henk P Roest2, Luc J W van der Laan2
1Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Abstract:
Primary sclerosing cholangitis (PSC) is a chronic, immune-mediated liver disease characterized by progressive inflammation and fibrosis of the bile ducts. Although much of the research has focused on genetic and autoimmune mechanisms, growing interest has emerged in the role of modifiable risk factors, including dietary and lifestyle factors, in the pathogenesis and progression of PSC. This review aims to provide a comprehensive synthesis of the current literature on dietary and lifestyle influences on PSC, with particular attention to underlying molecular pathways. Key factors discussed include smoking, alcohol consumption, physical activity, and medical history factors such as appendectomy, tonsillectomy, and hormonal therapies. Additionally, the review explores the impact of dietary components, such as coffee, vitamins, probiotics, and dietary fibers, on PSC progression. Potential mechanisms highlighted include alterations in bile acid metabolism, gut microbiota dysbiosis, disruption of intestinal barrier integrity, and modulation of innate and adaptive immune responses through cytokine signaling and pattern recognition receptor pathways. Emerging evidence also suggests that coffee constituents may influence oxidative stress pathways and fibrogenesis, whereas dietary fibers and probiotics may act through short-chain fatty acid production and anti-inflammatory signaling. Although the evidence for many of these factors remains inconclusive, these molecular insights point to diet-induced immunometabolism modulation as a promising area for therapeutic intervention. Further prospective studies and randomized trials are needed to clarify these mechanisms and develop targeted strategies to modify disease onset and progression.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Atherosclerosis III: Management
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Coronary Artery Disease I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
